Gene expression changes associated with acquired resistance to anti-EGFR therapy (cetuximab) in colorectal cancer cells
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Colorectal cancerThis series is part of our curated briefing on it.
- Samples
- 18 samples: 18 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE262796_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1093402 and SRA study SRP498671. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 18 sample titles: 18 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8179478 Cetuximab-sensitive DiFi-S – biol rep 1 [S37]
- GSM8179479 Cetuximab-sensitive DiFi-S – biol rep 2 [S38]
- GSM8179480 Cetuximab-sensitive DiFi-S – biol rep 3 [S39]
- GSM8179481 Cetuximab-resistant DiFi-R1 – biol rep 1 [S40]
- GSM8179482 Cetuximab-resistant DiFi-R1 – biol rep 2 [S41]
- GSM8179483 Cetuximab-resistant DiFi-R1 – biol rep 3 [S42]
- GSM8179484 Cetuximab-resistant DiFi-R2 – biol rep 1 [S43]
- GSM8179485 Cetuximab-resistant DiFi-R2 – biol rep 2 [S44]
- GSM8179486 Cetuximab-resistant DiFi-R2 – biol rep 3 [S45]
- GSM8179487 Cetuximab-sensitive LIM1215-S – biol rep 1 [S46]
- GSM8179488 Cetuximab-sensitive LIM1215-S – biol rep 2 [S47]
- GSM8179489 Cetuximab-sensitive LIM1215-S – biol rep 3 [S48]
- GSM8179490 Cetuximab-resistant LIM1215-R1 – biol rep 1 [S49]
- GSM8179491 Cetuximab-resistant LIM1215-R1 – biol rep 2 [S50]
- GSM8179492 Cetuximab-resistant LIM1215-R1 – biol rep 3 [S51]
- GSM8179493 Cetuximab-resistant LIM1215-R2 – biol rep 1 [S52]
- GSM8179494 Cetuximab-resistant LIM1215-R2 – biol rep 2 [S53]
- GSM8179495 Cetuximab-resistant LIM1215-R2 – biol rep 3 [S54]
- GSE250000 Bulk RNA-sequencing of transduced colorectal cancer cell line HCT-116 and breast cancer cell line MCF-7 overexpressing full-lenght p53β or p53β-stop-lost. 4 samples same disease briefing · shares colorectal
- GSE12032 Inherent gene signature of stage II and III colorectal cancer leads in individual recurrence 198 samples same disease briefing · shares colorectal
- GSE110009 Single cell transcriptome landscape of primary and metastatic tumor in colon cancer 76 samples same disease briefing
- GSE109308 Single-cell transcriptomic survey of adenomatous polyposis patients with germline APC mutations 97 samples same disease briefing
- GSE289766 Analysis of the mechanism of acquisition of chemotherapy resistance in colorectal cancer cell lines 27 samples shares resistance, colorectal, therapy
- GSE211434 Diverse immune suppressing cancer communications with myeloid cells prevent T cell activation and recruitment and provide resistance to cell cycle inhibitor therapy 81 samples shares resistance, therapy
- GSE292601 Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1 62 samples shares colorectal, therapy
- GSE309004 Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment 54 samples shares resistance, therapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.